Foot-and-mouth disease virus VP1 promotes viral replication by regulating the expression of chemokines and GBP1

Foot-and-mouth disease virus VP1 promotes viral replication by regulating the expression of chemokines and GBP1

Foot-and-mouth disease virus (FMDV) is an acute, highly contagious, and economically destructive pathogen of vesicular disease that affects domestic and wild cloven-hoofed animals. The FMDV VP1 protein is an important part of the nucleocapsid and plays a significant role during FMDV infection. Howev...

Full description

Bibliographic Details
Main Authors:	Li Yang, Hong Chen, Liqing Liu, Jingjing Song, Tian Feng, Yihan Li, Chao Shen, Lingbao Kong, Xiu Xin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Veterinary Science
Subjects:	RNA-seq transcriptome gene expression FMDV VP1 cytokine GBP1
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2022.937409/full

Similar Items

Preparation and Characterization of Nanoliposome Containing Isolated VP1 Protein of Foot and Mouth Disease Virus as a Model of Vaccine
by: M Kazemi, et al.
Published: (2022-02-01)

In silico Evolutionary Divergence Analysis Suggests the Potentiality of Capsid Protein VP2 in Serotype-Independent Foot-and-Mouth Disease Virus Detection
by: Israt Dilruba Mishu, et al.
Published: (2020-09-01)

GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy
by: Xiaohui Li, et al.
Published: (2023-08-01)

The transient expression of coat protein of Foot and Mouth Disease Virus (FMDV) in spinach (Spinacia oleracea) using Agroinfiltration
by: Maziar Habibi, et al.
Published: (2014-12-01)

Gbp3 is associated with the progression of lupus nephritis by regulating cell proliferation, inflammation and pyroptosis
by: Zhongfeng Zhang, et al.
Published: (2023-12-01)

Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3
by: Pathum Ekanayaka, et al.
Published: (2021-09-01)

Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes Type I Interferon Signaling via Degradation of Histone Deacetylase 5
by: Qing Gong, et al.
Published: (2024-03-01)

Function and mechanism of GBP1 in the development and progression of cervical cancer
by: Senyu Wang, et al.
Published: (2024-01-01)

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
by: Fan H, et al.
Published: (2023-05-01)

Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment
by: Ashenafi Kiros Wubshet, et al.
Published: (2024-04-01)

Tupaia GBP1 exploits autophagy to restrict herpes simplex virus type 1 infection
by: Tianle Gu, et al.
Published: (2022-12-01)

HSP70 positively regulates translation by interacting with the IRES and stabilizes the viral structural proteins VP1 and VP3 to facilitate duck hepatitis A virus type 1 replication
by: Yurui Jiang, et al.
Published: (2024-05-01)

GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
by: Yunfei Wang, et al.
Published: (2023-10-01)

GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
by: Ren Li, et al.
Published: (2022-09-01)

The function of guanylate binding protein 3 (GBP3) in human cancers by pan-cancer bioinformatics
by: Tongmeng Jiang, et al.
Published: (2023-03-01)

The IRF1/GBP5 axis promotes osteoarthritis progression by activating chondrocyte pyroptosis
by: Hao Tang, et al.
Published: (2024-01-01)

YTHDF1-mediated m6A modification of GBP4 promotes M1 macrophage polarization in acute lung injury
by: Fengan Cao, et al.
Published: (2025-01-01)

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity
by: Jun Xie, et al.
Published: (2023-06-01)

Porcine reproductive and respiratory syndrome virus non-structural protein 4 cleaves guanylate-binding protein 1 via its cysteine proteinase activity to antagonize GBP1 antiviral effect
by: Hong Duan, et al.
Published: (2022-07-01)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
by: Bo Liu, et al.
Published: (2021-05-01)

Construction of Recombinant Marek’s Disease Virus Co-Expressing VP1 and VP2 of Chicken Infectious Anemia Virus
by: Kai Li, et al.
Published: (2024-09-01)

GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer
by: Shun-Wen Cheng, et al.
Published: (2021-04-01)

Intervention Analysis of Daily GBP-USD Exchange Rates Occasioned by BREXIT
by: Ette Etuk, et al.
Published: (2016-12-01)

A GBP 130 derived peptide from Plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro
by: Jorge E Suarez, et al.
Published: (2000-08-01)

Somatic mosaicism and structural variability of GBP3 gene in atherosclerosis
by: A. A. Sleptsov, et al.
Published: (2019-12-01)

Antigenicity and Immunogenicity Analysis of the <em>E. coli</em> Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus
by: Guoxiu Li, et al.
Published: (2021-05-01)

The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT/MAPK/NF-κB pathways
by: Song Shen, et al.
Published: (2024-03-01)

VP0 Myristoylation Is Essential for Senecavirus A Replication
by: Peiyu Xiao, et al.
Published: (2024-07-01)

Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer
by: Mandana AmeliMojarad, et al.
Published: (2024-09-01)

Development of a Kit for Rapid Immunochromatographic Detection of Sacbrood Virus Infecting <i>Apis cerana</i> (AcSBV) Based on Polyclonal and Monoclonal Antibodies Raised against Recombinant VP1 and VP2 Expressed in <i>Escherichia coli</i>
by: Song Hee Lee, et al.
Published: (2021-12-01)

Dietary Immunoglobulin Y by Targeting Both GbpB and GtfB Enhances the Anticaries Effect in Rats
by: Yunxiao Du, et al.
Published: (2024-12-01)

Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products
by: Muhammad Hayat, et al.
Published: (2024-06-01)

The Structural Framework and Opening Appearance of the VP1-Pocket of Enteroviruses Correlated with Viral Thermostability
by: Xiaojing Lin, et al.
Published: (2024-08-01)

Genetic characterization of foot-and-mouth disease virus in cattle in Northern Egypt
by: Sarah G. Yousef, et al.
Published: (2025-01-01)

Recombinant Marek’s disease virus expressing VP1 and VP2 proteins provides robust immune protection against chicken infectious anemia virus
by: Chengfei Ge, et al.
Published: (2025-01-01)

m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs
by: Lu Ding, et al.
Published: (2022-04-01)

A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
by: Kun Meng, et al.
Published: (2023-01-01)

Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer
by: Farzaneh Rahvar, et al.
Published: (2020-11-01)

Enzymatic characterization and dominant sites of foot-and-mouth disease virus 2C protein
by: Saisai Zhou, et al.
Published: (2024-08-01)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
by: Sun Young Park, et al.
Published: (2022-12-01)